A guardian molecule ensures that liver cells do not lose their identity. The discovery is of great interest for cancer medicine because a change of identity of cells has come into focus as a ...

Rznomics announced on the 14th that its anticancer drug, RZ-001, has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for the treatment of Hepatocellular Carcinoma (HCC ...

However, the nation has now been embroiled in this "war" for over 50 years, and we are nowhere closer to victory, argues ...

Strangers and friends have raised more than $150,000 for a Seattle man's experimental life-saving cancer treatment after ... had a significant tumor in his liver. He then underwent a successful ...

With the widespread use of dietary supplements, concerns about the ingredients' accuracy and potential liver damage have increased. Research reveals a significant issue of mislabeling and ...

Chennai: A 58-year-old Bengaluru woman in advanced stages of cancer had exhausted most types ... multiple abdominal organs excluding the liver. "Most such cancers do not affect the liver," said ...

Feb. 6, 2025 — The research found that heavy drinkers with either diabetes, high blood pressure or a high waist circumference are as much as 2.4 times more likely to develop advanced liver ...

The early life exposures, including body weight at 10 years and maternal smoking around birth, were shown to influence ageing ...

France's parliament on Thursday voted to limit the production and sale of some items containing polluting and ...

A 35-year-old mom-of-three sadly died just days after being diagnosed with liver cancer after crucial signs tragically went ...

BESREMi is a preferred, FDA-approved option for both symptomatic low- and high-risk polycythemia vera patients. In the polycythemia vera space, BESREMi faces competition from drugs like ruxolitinib, a ...